12:06 PM EST - Medicago Inc. : announced that a scientific report entitled "Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza," was recently published in the peer-reviewed journal PLoS ONE. Scientists from Medicago, Research Institute of the McGill University Health Center, Montreal General Hospital, Québec, Canada, and University of Siena, Department Physiopatology Experimental Medicine and Public Health, Molecular Epidemiology Research Division, Siena, Italy, co-authored the scientific report. Medicago Inc.
shares T.MDG are trading up $0.01 at $0.59.
